Pfizer Inc. (PFE) is a biopharmaceutical company and manufacturer of health care products. The publicly-traded company owns several household brands—including Advil, Centrum, Lipitor, Lyrica, Prevnar, and Viagra—and manages a portfolio of health products. The company is one of the largest drugmakers, with a $204 billion market cap. 

Key Takeaways

  • The top four mutual fund holders of Pfizer shares own almost 7% of the company.
  • The Vanguard Total Stock Market Index is the top mutual fund holder of Pfizer shares with 2.8%. 
  • The four major mutual fund holders of Pfizer have all posted three-year annualized gains of 12% or better. 

Pfizer announced its third-quarter earnings on October 27, 2020, posting $12.1 billion in revenues for the quarter. Its earnings per share came in as $0.39. Not surprisingly, the largest investors of Pfizer are mutual funds. Here are the company's four largest mutual fund owners:

Vanguard Total Stock Market Index Fund (VTSMX)

The Vanguard Total Stock Market Index was launched in April 1992. Since then, the fund's assets have grown to $823.8 billion, and it invests primarily in U.S. large-cap stocks. With 157.1 million shares of Pfizer as of Nov. 30, 2020, VTSMX is the company's largest mutual fund holder. 

The Vanguard Total Stock Market Index Fund has a 11.64% three-year annualized return and a minimum investment of $3,000.

7.5%

The amount of Pfizer that is owned by Vanguard across all its funds.

Vanguard 500 Index Fund (VFINX)

The Vanguard 500 Index Fund Investor Shares seeks to provide investment results corresponding to the price and yield performance of the S&P 500 Index, its benchmark index, with a high degree of positive correlation. VFINX was issued by Vanguard in August 1976 and has assets of $620.2 billion.

With 114 million shares, the fund is Pfizer's second-largest mutual fund shareholder. The Vanguard 500 Index Fund has a 13.02% three-year annualized return and a minimum investment of $3,000.

SPDR S&P 500 ETF (SPY)

The SPDR S&P 500 ETF (SPY) is the first ETF to be introduced in the U.S. public market and remains one of the most popular to this day. The fund holds 57.8 million shares of Pfizer, a third-place ranking among the company's top mutual fund owners. The SPDR S&P 500 ETF has a three-year annualized return of yield of 13%.

Vanguard Institutional Index Fund (VINIX)

The Vanguard Institutional Index Fund Institutional Shares (VINIX) is an institutional fund that tracks the S&P 500 Index. The fund follows a passively managed, full replication approach invested in 506 stocks. With 47 million shares of Pfizer in its portfolio, VINIX is the company's fourth-largest mutual fund owner. 

The Vanguard Institutional Index Fund has a 13.14% three-year annualized return and a minimum investment of $3,000.